amotosalen has been researched along with ficusin in 7 studies
| Studies (amotosalen) | Trials (amotosalen) | Recent Studies (post-2010) (amotosalen) | Studies (ficusin) | Trials (ficusin) | Recent Studies (post-2010) (ficusin) |
|---|---|---|---|---|---|
| 179 | 18 | 103 | 1,049 | 37 | 331 |
| Protein | Taxonomy | amotosalen (IC50) | ficusin (IC50) |
|---|---|---|---|
| Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) | 3 | |
| Acetylcholinesterase | Homo sapiens (human) | 6.48 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cimino, G; Corash, L; Grass, J; Hei, DJ; Lin, L | 1 |
| Hanke, C; Hearst, JE; Johnson, BD; Talib, S; Truitt, RL | 1 |
| Corash, L; Hind, C; Lin, L; Mayaudon, V; van Rhenen , DJ; Vermeij, J | 1 |
| Ciaravino, V | 1 |
| Lin, L | 1 |
| Ciaravi, V; Dayan, AD; McCullough, T | 1 |
| Corash, L | 1 |
3 review(s) available for amotosalen and ficusin
| Article | Year |
|---|---|
Preclinical safety of a nucleic acid-targeted Helinx compound: a clinical perspective.
Topics: Animals; DNA; Drug Evaluation, Preclinical; Ficusin; Furocoumarins; Humans; Infection Control; Photosensitizing Agents; Platelet Transfusion; Ultraviolet Rays | 2001 |
Inactivation of cytomegalovirus in platelet concentrates using Helinx technology.
Topics: Animals; Blood Platelets; Cytomegalovirus; Cytomegalovirus Infections; Ficusin; Furocoumarins; Humans; Photochemotherapy; Photosensitizing Agents; Platelet Transfusion; Ultraviolet Rays | 2001 |
Pharmacokinetic and toxicology assessment of INTERCEPT (S-59 and UVA treated) platelets.
Topics: Animals; Blood Platelets; DNA; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Ficusin; Furocoumarins; Humans; In Vitro Techniques; Infection Control; Male; Mice; Photopheresis; Platelet Transfusion; Radiation-Sensitizing Agents; Rats; Toxicity Tests; Ultraviolet Rays | 2001 |
4 other study(ies) available for amotosalen and ficusin
| Article | Year |
|---|---|
Elimination of cytokine production in stored platelet concentrate aliquots by photochemical treatment with psoralen plus ultraviolet A light.
Topics: Blood Preservation; Cytokines; Depression, Chemical; DNA Adducts; Enzyme-Linked Immunosorbent Assay; Ficusin; Furocoumarins; Gamma Rays; Gene Expression Regulation; Humans; Interleukin-8; Leukocytes; Methoxsalen; Platelet Transfusion; Radiation-Sensitizing Agents; Time Factors; Trioxsalen; Ultraviolet Rays | 1999 |
Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
Topics: Animals; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Bone Marrow Transplantation; Cells, Cultured; Clonal Anergy; Cytokines; Cytotoxicity, Immunologic; Dose-Response Relationship, Immunologic; Ficusin; Furocoumarins; Graft vs Host Reaction; Immunosuppression Therapy; Lectins, C-Type; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Male; Mice; Mice, Inbred AKR; Mice, Inbred C57BL; PUVA Therapy; Radiation Chimera; Radiation-Sensitizing Agents; Receptors, Interleukin-2; T-Lymphocytes; T-Lymphocytes, Cytotoxic; Time Factors; Transplantation, Homologous | 1999 |
Functional characteristics of S-59 photochemically treated platelet concentrates derived from buffy coats.
Topics: Blood Platelets; Blood Preservation; Ficusin; Furocoumarins; Humans; Hydrogen-Ion Concentration; Oxygen Consumption; Photochemistry; Platelet Activation; Radiation-Sensitizing Agents | 2000 |
Bacterial contamination of platelet components: potential solutions to prevent transfusion-related sepsis.
Topics: Bacteria; Bacterial Infections; Blood Platelets; Disinfection; Ficusin; Furocoumarins; Humans; Nucleic Acids; Platelet Transfusion; Riboflavin; Risk Factors; Sepsis; Ultraviolet Rays | 2011 |